Average R&D cost to develop new biopharma compound 2013-2022

Published by
Matej Mikulic,
Mar 19, 2024
This statistic shows the average research and development cost for large and mid-sized biopharma companies to develop a new compound from discovery to market launch from 2013 to 2022. According to the data, average R&D costs showed a fluctuating tendency over the last six years.

Average cost to develop a compound for biopharma companies from 2013 to 2022 (in billion U.S. dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2023

Region

Worldwide

Survey time period

2013 to 2022

Special properties

12 large and 4 mid-to-large biopharma companies by market cap

Supplementary notes

Includes cost for development of a compound from discovery to launch.
Numbers have been rounded.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Medical biotech industry "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Medical biotech industry

Global overview

7

U.S. and European landscape

6

Focus: U.S. companies

8

Research & development

6

Products

5

Funding/M&A/IPOs

6

Focus: RNA/mRNA

4

Further Content: You might find this interesting as well

Topics

Biotech drugsGlobal pharmaceutical industryCancer in the U.S.AmgenCoronavirus (COVID-19) vaccines and treatments
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu